Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
0.918
+0.020 (2.25%)
Jun 29, 2026, 2:08 PM EDT - Market open
Lite Strategy Employees
Lite Strategy had 4 employees as of June 30, 2025. The number of employees decreased by 24 or -85.71% compared to the previous year.
Employees
4
Change (1Y)
-24
Growth (1Y)
-85.71%
Revenue / Employee
n/a
Profits / Employee
-$15,205,000
Market Cap
31.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Kyntra Bio | 34 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Barinthus Biotherapeutics | 14 |
LITS News
- 10 days ago - Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam - GlobeNewsWire
- 11 days ago - Lite Strategy leads strategic investment in LitVM - TheFly
- 11 days ago - Lite Strategy Leads Strategic Investment in LitVM - GlobeNewsWire
- 6 weeks ago - Lite Strategy Reports Fiscal 2026 Third Quarter Results - GlobeNewsWire
- 6 weeks ago - Lite Strategy Quarterly report: Q3 2026 - Filings
- 6 weeks ago - Lite Strategy Earnings release: Q3 2026 - Filings
- 4 months ago - Lite Strategy reports Q2 EPS (82c) vs. (40c) last year - TheFly
- 4 months ago - Lite Strategy to continue to evaluate strategic investments in 2H of 2026 - TheFly